Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers
暂无分享,去创建一个
[1] B. Harrison,et al. Modulation of brain structure by catechol‐O‐methyltransferase Val158Met polymorphism in chronic cannabis users , 2014, Addiction biology.
[2] E T Bullmore,et al. Cocaine dependence: a fast-track for brain ageing? , 2013, Molecular Psychiatry.
[3] K. Franson,et al. The Pharmacologic and Clinical Effects of Medical Cannabis , 2013, Pharmacotherapy.
[4] N. Friedman,et al. CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging , 2013, Proceedings of the National Academy of Sciences.
[5] Y. Boo,et al. Analysis of serum cytokine/chemokine profiles affected by aging and exercise in mice. , 2012, Cytokine.
[6] Richie Poulton,et al. Persistent cannabis users show neuropsychological decline from childhood to midlife , 2012, Proceedings of the National Academy of Sciences.
[7] H. Christensen,et al. Cannabis use and cognitive function: 8-year trajectory in a young adult cohort. , 2011, Addiction.
[8] M. Takeda,et al. Leptin Has a Priming Effect on Eotaxin-Induced Human Eosinophil Chemotaxis , 2011, International Archives of Allergy and Immunology.
[9] J. Kaye,et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function , 2011 .
[10] P. Dandona,et al. Suppressive Effect of Insulin Infusion on Chemokines and Chemokine Receptors , 2010, Diabetes Care.
[11] R. Lam,et al. Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. , 2009, The international journal of neuropsychopharmacology.
[12] Philip D. Harvey,et al. Is schizophrenia a syndrome of accelerated aging? , 2008, Schizophrenia bulletin.
[13] H. Corrêa,et al. Increased serum levels of CCL11/eotaxin in schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[14] N. Solowij,et al. The chronic effects of cannabis on memory in humans: a review. , 2008, Current drug abuse reviews.
[15] H. S. Park,et al. Effect of exercise training on plasma visfatin and eotaxin levels. , 2007, European journal of endocrinology.
[16] A. Lokshin,et al. Dynamic alteration of soluble serum biomarkers in healthy aging. , 2007, Cytokine.
[17] Peter B. Jones,et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review , 2007, The Lancet.
[18] Jordan W. Smoller,et al. Telomere Shortening and Mood Disorders: Preliminary Support for a Chronic Stress Model of Accelerated Aging , 2006, Biological Psychiatry.
[19] J. Stirling,et al. Cannabis-Induced Psychosis-Like Experiences Are Associated with High Schizotypy , 2006, Psychopathology.
[20] J. Morrison,et al. The aging brain: morphomolecular senescence of cortical circuits , 2004, Trends in Neurosciences.
[21] Jean Addington,et al. A depression rating scale for schizophrenics , 1990, Schizophrenia Research.
[22] P. Landfield,et al. Quantitative changes in hippocampal structure following long-term exposure to Δ 9-tetrahydrocannabinol: possible mediation by glucocorticoid systems , 1988, Brain Research.